Background: Lynch syndrome is one of the most common genetic predispositions to many cancers, most of which do not have a consensus recommendation for screening.
Aims: We studied in our region the value of a systematized and coordinated follow-up program for patients with Lynch syndrome on all organs at risk.
Methods: A multicenter prospective cohort evaluation was performed, from January 2016 to June 2021.